Sculpta Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

Sculpta Bio General Information

Description

Operator of a neurotherapeutics company developing protein sculpting drugs intended to treat brain diseases using protein sculpting drugs. The company offers protein sculpting therapeutics- drugs that change the structure and function of disease-causing proteins in the brain using programmable RNA medicines, enabling customers to develop safer, more specific, and more effective therapies for devastating brain disorders compared to traditional genomic medicines.

Contact Information

Website
www.sculpta.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States

Sculpta Bio Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sculpta Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jan-2026 Completed Startup
1. Seed Round 01-Mar-2025 Completed Startup
To view Sculpta Bio’s complete valuation and funding history, request access »

Sculpta Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sculpta Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
California Life Sciences Accelerator/Incubator
GreyMatter Capital Venture Capital Minority
NFX Venture Capital Minority
Not Boring Venture Capital Minority
PsyMed Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Sculpta Bio FAQs

  • When was Sculpta Bio founded?

    Sculpta Bio was founded in 2024.

  • Where is Sculpta Bio headquartered?

    Sculpta Bio is headquartered in San Francisco, CA.

  • What is the size of Sculpta Bio?

    Sculpta Bio has 7 total employees.

  • What industry is Sculpta Bio in?

    Sculpta Bio’s primary industry is Drug Discovery.

  • Is Sculpta Bio a private or public company?

    Sculpta Bio is a Private company.

  • What is Sculpta Bio’s current revenue?

    The current revenue for Sculpta Bio is .

  • How much funding has Sculpta Bio raised over time?

    Sculpta Bio has raised $2.6M.

  • Who are Sculpta Bio’s investors?

    California Life Sciences, GreyMatter Capital, NFX, Not Boring, and PsyMed Ventures are 5 of 7 investors who have invested in Sculpta Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process